Siemens Healthineers to acquire cancer treatment company Varian for $16.4B
Under the agreed transaction, Siemens Healthineers will acquire all shares in Varian for $177.50 each in cash, representing a 24% premium to the U.S. company’s closing price on Friday.
0 comments:
Post a Comment